Researchers from Tohoku University launched the study in 1986 under Professor Yutaka Imai in response to the high burden of hypertension and stroke in Ohasama, Iwate Prefecture.
The shift also comes as pharmaceutical companies invest in newer technologies that could change how influenza vaccines are developed and manufactured.
The Photon Counting Sensor Fab is the only facility of its kind in Europe and will produce semiconductor sensors used in advanced X-ray imaging.
Exegenesis Bio designed EMC181 to improve the delivery of genetic medicines to muscle tissue while limiting exposure to the liver.
Following the transaction, the LSDx business will operate independently under the name Aluris Sciences.
Axogen expects to complete the transaction in the fourth quarter of 2026, adding BioCircuit’s NerveTape to its portfolio.
The decision follows WHO’s prequalification of the vaccine’s single dose presentation in March 2025 and Gavi’s decision in July 2025 to establish a maternal RSV vaccine programme.
The facility will add to ABEC’s existing manufacturing operations in Bethlehem, Pennsylvania, and Springfield, Missouri, as well as its facilities in Fermoy and Kells, Ireland.
Her contributions to patient access, community engagement and healthcare capacity have earned her recognition including the British Empire Medal.
Moscow has used computer vision in healthcare for more than six years, with more than 70 AI services supporting doctors in analysing medical images, including CT scans, MRI examinations, and X-rays.